Long-Term Monitoring of Everolimus Concentrations in Routine Clinical Practice: Evaluation of Patient Percentiles as Quality Indicator and Impact of Analytical Method Change

Anders O. Larsson, Anna-Karin Hamberg, Mats B. Eriksson

Open source

DOI
10.3390/ph19091412
Published
2026-09-07
Container
Pharmaceuticals
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/ph19091412,
  title = {Long-Term Monitoring of Everolimus Concentrations in Routine Clinical Practice: Evaluation of Patient Percentiles as Quality Indicator and Impact of Analytical Method Change},
  author = {Anders O. Larsson and Anna-Karin Hamberg and Mats B. Eriksson},
  year = {2026},
  journal = {Pharmaceuticals},
  doi = {10.3390/ph19091412},
  url = {https://doi.org/10.3390/ph19091412}
}

RIS

TY  - JOUR
TI  - Long-Term Monitoring of Everolimus Concentrations in Routine Clinical Practice: Evaluation of Patient Percentiles as Quality Indicator and Impact of Analytical Method Change
AU  - Anders O. Larsson
AU  - Anna-Karin Hamberg
AU  - Mats B. Eriksson
PY  - 2026
JO  - Pharmaceuticals
DO  - 10.3390/ph19091412
UR  - https://doi.org/10.3390/ph19091412
ER  - 

APA

Larsson, A. O., Hamberg, A., & Eriksson, M. B. (2026). Long-Term Monitoring of Everolimus Concentrations in Routine Clinical Practice: Evaluation of Patient Percentiles as Quality Indicator and Impact of Analytical Method Change. Pharmaceuticals. https://doi.org/10.3390/ph19091412

Source records